Giagounidis A - Search Results

1

Luspatercept for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes (PACE-MDS): a multicentre, open-label phase 2 dose-finding study with long-term extension study.

Platzbecker U, Germing U, Götze KS, Kiewe P, Mayer K, Chromik J, Radsak M, Wolff T, Zhang X, Laadem A, Sherman ML, Attie KM, Giagounidis A. Platzbecker U, et al. Among authors: giagounidis a. Lancet Oncol. 2017 Oct;18(10):1338-1347. doi: 10.1016/S1470-2045(17)30615-0. Epub 2017 Sep 1. Lancet Oncol. 2017. PMID: 28870615 Clinical Trial.

2

Pseudomonas aeruginosa orbital phlegmon in a patient treated for myelodysplastic syndrome with concomitant Sjögren's syndrome.

Giagounidis AA, Giagounidis AS, Germing U, Koch JA, Aul C. Giagounidis AA, et al. Among authors: giagounidis as. Eur J Med Res. 1999 Jan 26;4(1):27-30. Eur J Med Res. 1999. PMID: 9892572

3

[Myelodysplastic syndromes. Diagnosis and therapeutic strategies].

Aul C, Giagounidis A, Germing U, Ganser A. Aul C, et al. Among authors: giagounidis a. Med Klin (Munich). 2002 Nov 15;97(11):666-76. doi: 10.1007/s00063-002-1210-4. Med Klin (Munich). 2002. PMID: 12434275 Review. German.

4

Refractory anemia with excess of blasts in transformation: analysis of reclassification according to the WHO proposals.

Strupp C, Gattermann N, Giagounidis A, Aul C, Hildebrandt B, Haas R, Germing U. Strupp C, et al. Among authors: giagounidis a. Leuk Res. 2003 May;27(5):397-404. doi: 10.1016/s0145-2126(02)00220-5. Leuk Res. 2003. PMID: 12620291

5

Prognostic indicators and scoring systems for predicting outcome in patients with myelodysplastic syndromes.

Aul C, Giagounidis A, Heinsch M, Germing U, Ganser A. Aul C, et al. Among authors: giagounidis a. Rev Clin Exp Hematol. 2004 Dec 1;8(2):E1. Rev Clin Exp Hematol. 2004. PMID: 16027099 Review.

6

Refractory anaemia with excess of blasts (RAEB): analysis of reclassification according to the WHO proposals.

Germing U, Strupp C, Kuendgen A, Aivado M, Giagounidis A, Hildebrandt B, Aul C, Haas R, Gattermann N. Germing U, et al. Among authors: giagounidis a. Br J Haematol. 2006 Jan;132(2):162-7. doi: 10.1111/j.1365-2141.2005.05853.x. Br J Haematol. 2006. PMID: 16398650 Free article.

7

Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes.

Germing U, Strupp C, Kuendgen A, Isa S, Knipp S, Hildebrandt B, Giagounidis A, Aul C, Gattermann N, Haas R. Germing U, et al. Among authors: giagounidis a. Haematologica. 2006 Dec;91(12):1596-604. Haematologica. 2006. PMID: 17145595

8

Presence of peripheral blasts in refractory anemia and refractory cytopenia with multilineage dysplasia predicts an unfavourable outcome.

Knipp S, Strupp C, Gattermann N, Hildebrandt B, Schapira M, Giagounidis A, Aul C, Haas R, Germing U. Knipp S, et al. Among authors: giagounidis a. Leuk Res. 2008 Jan;32(1):33-7. doi: 10.1016/j.leukres.2007.02.021. Epub 2007 Apr 6. Leuk Res. 2008. PMID: 17412418

9

Platelet morphology, platelet mass, platelet count and prognosis in patients with myelodysplastic syndromes.

Germing U, Platzbecker U, Giagounidis A, Aul C. Germing U, et al. Among authors: giagounidis a. Br J Haematol. 2007 Aug;138(3):399-400. doi: 10.1111/j.1365-2141.2007.06655.x. Epub 2007 Jun 6. Br J Haematol. 2007. PMID: 17555472 Free article. No abstract available.

10

Intensive chemotherapy is not recommended for patients aged >60 years who have myelodysplastic syndromes or acute myeloid leukemia with high-risk karyotypes.

Knipp S, Hildebrand B, Kündgen A, Giagounidis A, Kobbe G, Haas R, Aul C, Gattermann N, Germing U. Knipp S, et al. Among authors: giagounidis a. Cancer. 2007 Jul 15;110(2):345-52. doi: 10.1002/cncr.22779. Cancer. 2007. PMID: 17559141 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

216 results

Search Page